New Analysis Shows PrimeC Significantly Improves Key miRNAs in ALS Patients
Go back to New Analysis Shows PrimeC Significantly Improves Key miRNAs in ALS Patients| (NASDAQ: NRSN) | Delayed: 7.05 -0.35 (4.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.40 | 52 Week High | $ | |||
| Open | $7.20 | 52 Week Low | $ | |||
| Day High | $7.20 | P/E | N/A | |||
| Day Low | $7.05 | EPS | $ | |||
| Volume | 2,596 | |||||
